Bay of Plenty Times
  • Bay of Plenty Times home
  • Latest news
  • Business
  • Opinion
  • Lifestyle
  • Property
  • Sport
  • Video
  • Death notices
  • Classifieds

Subscriptions

  • Herald Premium
  • Viva Premium
  • The Listener
  • BusinessDesk

Sections

  • Latest news
  • On The Up
  • Business
  • Opinion
  • Lifestyle
  • Property
    • All Property
    • Residential property listings
  • Rural
    • All Rural
    • Dairy farming
    • Sheep & beef farming
    • Horticulture
    • Animal health
    • Rural business
    • Rural life
    • Rural technology
  • Sport

Locations

  • Coromandel & Hauraki
  • Katikati
  • Tauranga
  • Mount Maunganui
  • Pāpāmoa
  • Te Puke
  • Whakatāne
  • Rotorua

Media

  • Video
  • Photo galleries
  • Today's Paper - E-Editions
  • Photo sales
  • Classifieds

Weather

  • Thames
  • Tauranga
  • Whakatāne
  • Rotorua

NZME Network

  • Advertise with NZME
  • OneRoof
  • Driven Car Guide
  • BusinessDesk
  • Newstalk ZB
  • Sunlive
  • ZM
  • The Hits
  • Coast
  • Radio Hauraki
  • The Alternative Commentary Collective
  • Gold
  • Flava
  • iHeart Radio
  • Hokonui
  • Radio Wanaka
  • iHeartCountry New Zealand
  • Restaurant Hub
  • NZME Events

SubscribeSign In
Advertisement
Advertise with NZME.
Home / Bay of Plenty Times

Keytruda study to be done by BOPDHB

Bay of Plenty Times
26 Sep, 2016 01:12 AM2 mins to read

Subscribe to listen

Access to Herald Premium articles require a Premium subscription. Subscribe now to listen.
Already a subscriber?  Sign in here

Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech.
‌
Save

    Share this article

Photo/File

Photo/File

A Keytruda study will be undertaken by the Bay of Plenty District Health Board's Clinical Trials Unit to look into the effectiveness of the drug.

The long term study will look at the results of Keytruda (pembrolizumab) being given with Epacadostat which will take place on the Tauranga Hospital campus.

Pharmac agreed to fund the drug for advanced melanoma patients from the beginning of September.

The Tauranga-based Clinical Trials unit was one of two sites in New Zealand selected to conduct the research study which looked at whether Keytruda was more effective in preventing Melanoma progression when given with another cancer drug, Epacadostat, rather than on its own.

Six patients from the Bay of Plenty were taking part in the study which started in June.

Eligible patients were referred by their oncologists and their progress was being closely monitored.

The study would run for two years in Tauranga and in Dunedin.

The Clinical Trials Unit (CTU) had experienced significant growth since it was established in 2009 with two staff.

It now had a team of nine research nurses, a research assistant and research manager, earlier this year it was moved into a purpose built facility at 850 Cameron Road.

The CTU was headed by Professor Peter Gilling and undertook clinical trials and research for a variety of pharmaceutical and device companies and research projects.

The majority of the trials were multi-centred, international, pharmaceutical studies; in the fields of oncology, rheumatology, gastroenterology, respiratory, cardiology, infectious diseases and original research.

Advertisement
Advertise with NZME.
Advertisement
Advertise with NZME.
Save

    Share this article

Latest from Bay of Plenty Times

Bay of Plenty Times

'Palpable grief': Motorcyclist who killed two people had 11 previous driving convictions

12 Jul 11:00 PM
Bay of Plenty Times

Second venomous sea snake washes ashore in Coromandel

12 Jul 06:00 AM
Sport

'My moment': NZ-born boxer becomes first Māori to be crowned undisputed world champ

12 Jul 03:58 AM

From early mornings to easy living

sponsored
Advertisement
Advertise with NZME.

Latest from Bay of Plenty Times

'Palpable grief': Motorcyclist who killed two people had 11 previous driving convictions

'Palpable grief': Motorcyclist who killed two people had 11 previous driving convictions

12 Jul 11:00 PM

The couple were walking home when Mark Kimber sped through an intersection and hit them.

Second venomous sea snake washes ashore in Coromandel

Second venomous sea snake washes ashore in Coromandel

12 Jul 06:00 AM
'My moment': NZ-born boxer becomes first Māori to be crowned undisputed world champ

'My moment': NZ-born boxer becomes first Māori to be crowned undisputed world champ

12 Jul 03:58 AM
Puchner makes history with silver at U23 canoe slalom world titles

Puchner makes history with silver at U23 canoe slalom world titles

12 Jul 03:37 AM
Solar bat monitors uncover secrets of Auckland’s night sky
sponsored

Solar bat monitors uncover secrets of Auckland’s night sky

NZ Herald
  • About NZ Herald
  • Meet the journalists
  • Newsletters
  • Classifieds
  • Help & support
  • Contact us
  • House rules
  • Privacy Policy
  • Terms of use
  • Competition terms & conditions
  • Our use of AI
Subscriber Services
  • Bay of Plenty Times e-edition
  • Manage your print subscription
  • Manage your digital subscription
  • Subscribe to Herald Premium
  • Subscribe to the Bay of Plenty Times
  • Gift a subscription
  • Subscriber FAQs
  • Subscription terms & conditions
  • Promotions and subscriber benefits
NZME Network
  • Bay of Plenty Times
  • The New Zealand Herald
  • The Northland Age
  • The Northern Advocate
  • Waikato Herald
  • Rotorua Daily Post
  • Hawke's Bay Today
  • Whanganui Chronicle
  • Viva
  • NZ Listener
  • Newstalk ZB
  • BusinessDesk
  • OneRoof
  • Driven Car Guide
  • iHeart Radio
  • Restaurant Hub
NZME
  • About NZME
  • NZME careers
  • Advertise with NZME
  • Digital self-service advertising
  • Book your classified ad
  • Photo sales
  • NZME Events
  • © Copyright 2025 NZME Publishing Limited
TOP